drugset / Trial / NCT00270517

Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

NCT00270517

Phase 2 Unknown 250 enrolled Enanta Pharmaceuticals, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the efficacy, safety and tolerability of EDP-420 versus another oral antibiotic in the treatment of community acquired pneumonia

Timeline

Start
2005-12
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MODITHROMYCIN Small molecule
Subject Telithromycin Small molecule

Indications

No indication recorded.